Latest Updates
-
Deepika Padukone Wears ₹90,000 Gold Kurta Set As Ranveer Singh, Daughter Dua Twin For Baby Devi’s Name Reveal -
Women, Menopause And Bone Health: Doctor Explains Why Osteoporosis Risk Rises After 40 -
Can Breast Cancer Be Detected Before Symptoms Appear? A Doctor Explains The Role Of Screening -
Papankusha Ekadashi 2026: October 21 Or 22? Know The Correct Date, Tithi And Significance -
OTT Releases This Week (October 19–25): New Movies And Series On Netflix, Prime Video, JioHotstar And Zee5 -
Police Commemoration Day 2026: Know The History, Significance And Programmes Planned Across India This Year -
Deepika Padukone And Ranveer Singh Announce Second Daughter’s Name On Dussehra, Share Family Photo -
Who Was Karthik Sabesh? Tamil Actor Passes Away At 37, Days After Uncle And Composer Deva’s Death -
Who Is Ravleen Varghese? Meet The First Malayali Model To Walk The Victoria’s Secret Runway -
World Osteoporosis Day 2026: A Minor Fall, A Major Fracture — Doctor On Why Older Adults Should Be Careful
Therapeutic Target For Cancer Identified

The research team has identified seven different receptors on T cells that can suppress immune responses during a long battle with an infectious pathogen or against developing cancer. Study's lead author, E. John Wherry, Ph.D., an assistant professor in Wistar''s Immunology Program said that chronic over-stimulation of the immune system can 'exhaust' immune cells rendering them ineffective.
The key finding is that these new receptors likely control different aspects of T cell responses, such as division or expansion, controlling viral replication, and local killing of infected cells versus secretion of long-range active antiviral proteins.
"This amount of control over T cells" response is remarkable. It suggests that layers of negative regulation exist on exhausted T cells from co-expression of multiple inhibitory receptors," Nature quoted him as saying. "My bet is that these receptors inhibit different aspects of the T cells" response, but that the net result of their activation is to turn specific T cell populations off.
"We are starting to see a picture emerging of a really tuneable array of inhibitory receptors expressed on T cells. That suggests it may be possible to not only dramatically enhance antiviral or antitumor T cell responses, but also to fine tune which response you want to enhance in order to reverse T cell exhaustion and continue fighting an infection or disease.
"This presents us with a great clinical opportunity. T cells have a lot of weapons at their disposal to control viral infection and most of them are disarmed when these cells become exhausted. "It may be possible to selectively rearm T cells while generally reinvigorating them," he added.
This brings in a ray of hope in the field of cancer research, hopefully the latest findings will fetch long term results.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
